Panong, Rolando .

HRN: 26-72-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/15/2025
09/22/2025
IV
2.25g
Q6hr
Perforated Peptic Ulcer
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: